Optic neuritis, its differential diagnosis and management

Open Ophthalmology Journal

Volumn 6, Issue , 2012, Pages 65-72

  Hoorbakht, Hedieh ^a   Bagherkashi, Farid ^a  

^a Bharati Vidyapeeth's Medical College   (India)

Author keywords

Differential diagnosis of optic neuritis; Multiple sclerosis; Neuromyelitis optica; Optic neuritis

Indexed keywords

BETA1A INTERFERON; CORTICOSTEROID; DEXAMETHASONE; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; STEROID; SUCCINIC ACID; ALBUMIN; GLUCOSE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTIC ACID; OLIGOCLONAL BAND; PROTEIN;

ACNE; ACUTE PANCREATITIS; ANTERIOR ISCHEMIC OPTIC NEUROPATHY; ASTHENIA; CEREBROSPINAL FLUID; CHILL; CLINICAL EXAMINATION; CLINICAL FEATURE; COLOR VISION; CONSTIPATION; DEPRESSION; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EVOKED VISUAL RESPONSE; EYE EDEMA; FACIAL FLUSHING; FATIGUE; FLUSHING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; LEBER HEREDITARY OPTIC NEUROPATHY; MONOTHERAPY; MOOD DISORDER; MULTIPLE SCLEROSIS; MYALGIA; MYELOOPTIC NEUROPATHY; NAUSEA; NEUROLOGIC EXAMINATION; NEURORETINITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PAIN; PAPILLITIS; PATHOPHYSIOLOGY; PERINEURITIS; PREVALENCE; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RELAPSE; RETINA MACULOPATHY; RETROBULBAR OPTIC NEUROPATHY; REVIEW; RISK REDUCTION; SIDE EFFECT; SLEEP DISORDER; STOMACH DISEASE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISION; VISUAL ACUITY; VISUAL FIELD; VOMITING; WEIGHT GAIN; ALLERGIC REACTION; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL (TOPIC); COLOR VISION DEFECT; CONTRAST SENSITIVITY; DEMYELINATION; ELECTRORETINOGRAPHY; FEVER; FLUORESCENCE ANGIOGRAPHY; HEADACHE; INCIDENCE; MYELITIS; NAUSEA AND VOMITING; OPTIC NERVE DISEASE; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RETINAL NERVE FIBER LAYER THICKNESS; SLIT LAMP; VISUAL EVOKED POTENTIAL; VISUAL IMPAIRMENT;

EID: 84865131675     PISSN: None     EISSN: 18743641     Source Type: Journal    
DOI: 10.2174/1874364101206010065     Document Type: Review

References (35)

1. Foroozan R, Buono LM, Savino PJ, Sergott RC. Acute demyelinating optic neuritis. Curr Opin Ophthalmol 2002; 13(6): 375-80.
2. Shams PN, Plant GT. Optic neuritis: a review. Int MS J 2009; 16(3): 82-9.
3. Vedula SS, Brodney-Folse S, Gal RL, Beck R. Corticosteroids for treating optic neuritis. Cochrane Database Syst Rev 2007; (1): CD001430.
4. Menon V, Saxena R, Misra R, Phuljhele S. Management of optic neuritis. Indian J Ophthalmol 2011; 59(2): 117-22.
5. Dooley MC, Foroozan R. Optic neuritis. J Ophthalmic Vis Res 2010; 5(3): 182-7.
6. Beck RW, Cleary PA, Optic Neuritis Study G. Optic neuritis treatment trial: one-year follow-up results. Arch Ophthalmol 1993; 111(6): 773-5.
7. Katz B. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial. Trans Am Ophthalmol Soc 1995; 93: 685-708.
8. Pau D, Al Zubidi N, Yalamanchili S, Plant GT, Lee AG. Optic Neuritis Eye 2011; 25(7): 833-42.
9. Voss E, Raab P, Trebst C, Stangel M. Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis. Ther Adv Neurol Disord 2011; 4(2): 123-34.
10. Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med 2006; 354(12): 1273-80.
11. Mittal A, Mittal S, Bharati MJ, Ramakrishnan R, Saravanan S, Sathe PS. Optic neuritis associated with chikungunya virus infection in South India. Arch Ophthalmol 2007; 125(10): 1381-6.
12. Moradian S, Ahmadieh H. Early onset optic neuritis following measles-rubella vaccination. J Ophthalmic Vis Res 2008; 3(2): 118-22.
13. Aragao RE, Barreira IM, Lima LN, Rabelo LP, Pereira FB. [Bilateral optic neuritis after dengue viral infection: case report]. Arq Bras Oftalmol 2010; 73(2): 175-8.
14. Plant GT. Optic neuritis and multiple sclerosis. Curr Opin Neurol 2008; 21(1): 16-21.
15. Dutt M, Tabuena P, Ventura E, Rostami A, Shindler KS. Timing of corticosteroid therapy is critical to prevent retinal ganglion cell loss in experimental optic neuritis. Invest Ophthalmol Vis Sci 2010; 51(3): 1439-45.
16. Ayuso Blanco T, Aliseda D, Ajuria I, Zandio B, Mayor S, Navarro MC. Inflammatory optic neuritis. An Sist Sanit Navar 2009; 32(2): 249-63.
17. Jung JJ, Baek SH, Kim US. Analysis of the causes of optic disc swelling. Korean J Ophthalmol 2011; 25(1): 33-6.
18. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002; 360(9349): 1953-62.
19. Silverman SE, Hart WM Jr, Gordon MO, Kilo C. The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage. Invest Ophthalmol Vis Sci 1990; 31(9): 1895-902.
20. Duffy CJ. The consequences of optic neuritis: more than meets the eye. Neurology 2011; 76(24): 2052-3.
21. Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist 2007; 13(2): 57-72.
22. LopateguiCabezas I, Cervantes Llano M, Penton Rol G. Optic neuromyelitis. Main differences with multiple sclerosis. An Med Interna 2008; 25(6): 294-6.
23. Osborne BJ, Volpe NJ. Optic neuritis and risk of MS: differential diagnosis and management. Cleve Clin J Med 2009; 76(3): 181-90.
24. Pandit L, Murthy JM. Treatment of multiple sclerosis. Ann Indian Acad Neurol 2011; 14(Suppl 1): S65-9.
25. Pro MJ, Pons ME, Liebmann JM, et al. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci 2006; 250(1-2): 114-9.
26. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296(23): 2832-8.
27. Kampman MT, Brustad M. Vitamin D: a candidate for the environmental effect in multiple sclerosis -observations from Norway. Neuroepidemiology 2008; 30(3): 140-6.
28. Mehta B, Ramanathan M, Weinstock-Guttman B. Vitamin D and multiple sclerosis: can vitamin D prevent disease progression? Expert Rev Neurother 2011; 11(4): 469-71.
29. Hayreh SS. Anterior ischaemic optic neuropathy. Differentiation of arteritic from non-arteritic type and its management. Eye 1990; 4(Pt 1): 25-41.
30. Luneau K, Newman NJ, Biousse V. Ischemic optic neuropathies. Neurologist 2008; 14(6): 341-54.
31. Mehrotra A, Jaffery N, Saxena R, Menon V. Comparative evaluation of megadose methylprednisolone with dexamethasone for treatment of primary typical optic neuritis. Indian J Ophthalmol 2007; 55(5): 355-9.
32. Sethi H, Sharma P, Tandon R, Khokhar S, Menon V. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: A clinical case series. Indian J Ophthalmol 2006; 54(3): 177-83.
33. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58(3): 383-91.
34. Kallenbach K, Frederiksen J. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol 2007; 14(8): 841-9.
35. Beck RW, Cleary PA, Trobe JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med 1993; 329(24): 1764-9.